Category Archives: Cancer and neoplasms
Oct
Credit: Pixabay/CC0 Public Domain A new editorial paper was published in Oncoscience, titled “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.” In their new editorial, researchers Deepak Bhamidipati and Vivek Subbiah from the Sarah Cannon Research Institute discuss lurbinectedin as a method to treat neuroendocrine tumors (NETs). NETs encompass […]
Impact Journals LLC “Several ongoing trials hope to further elucidate the role of lurbinectedin in highgrade neuroendocrine neoplasms […]” BUFFALO, NY- October 6, 2023 – A new editorial paper was published in Oncoscience (Volume 10) on June 14, 2023, entitled, “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.” In […]
Oct
When it comes to cancer, early detection is crucial. The sooner a tumor is found, the better the chances for successful treatments and outcomes. However, cancer doesn’t always present noticeable symptoms until it has progressed. Scientists are racing to develop tools for early diagnosis, and a liquid biopsy method now shows promise in detecting traces […]
Oct
Introduction Extracellular vesicles (EVs) are membranous structures located outside of cellular boundaries, exhibiting diameters ranging from 40–1000 nm.1 Furthermore, these substances are sourced from organic entities and cellular structures, encompassing plants, animals, and microorganisms.2 EVs were found to participate in the horizontal transfer of bioactive cargos, including proteins, nucleic acids (DNA, mRNA, and microRNA), as […]
Cancer and neoplasms
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms
Oct
Abstract MALAT1 long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, MALAT1 expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from clinico-biological subtypes of chronic lymphocytic leukemia (CLL, n = 266), paired Richter transformation (RT, n = 6) and follicular lymphoma (FL, n = 61). In peripheral blood (PB) CLL samples, […]
LOS ANGELES, Oct. 5, 2023 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway alterations, today announced that two posters will be presented at the upcoming North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium, taking place October 4-6, 2023, in Montreal, Canada. Details of the […]
Oncologists treating ovarian cancer need to be proactive to prevent or reduce the likelihood of adverse effects associated with poly (ADP-ribose) polymerase (PARP) inhibitors, noted authors of a review in the ASCO Educational Book. William Tew, MD, of Memorial Sloan Kettering Cancer Center in New York City, and colleagues discuss strategies to improve tolerance to […]